366 related articles for article (PubMed ID: 25470995)
1. Metal-chloroquine derivatives as possible anti-malarial drugs: evaluation of anti-malarial activity and mode of action.
Navarro M; Castro W; Madamet M; Amalvict R; Benoit N; Pradines B
Malar J; 2014 Dec; 13():471. PubMed ID: 25470995
[TBL] [Abstract][Full Text] [Related]
2. Toward a novel metal-based chemotherapy against tropical diseases. 7. Synthesis and in vitro antimalarial activity of new gold-chloroquine complexes.
Navarro M; Vásquez F; Sánchez-Delgado RA; Pérez H; Sinou V; Schrével J
J Med Chem; 2004 Oct; 47(21):5204-9. PubMed ID: 15456263
[TBL] [Abstract][Full Text] [Related]
3. Antiplasmodial activity of chloroquine analogs against chloroquine-resistant parasites, docking studies and mechanisms of drug action.
de Souza NB; Carmo AM; da Silva AD; França TC; Krettli AU
Malar J; 2014 Dec; 13():469. PubMed ID: 25440372
[TBL] [Abstract][Full Text] [Related]
4. Malagashanine potentiates chloroquine antimalarial activity in drug resistant Plasmodium malaria by modifying both its efflux and influx.
Ramanitrahasimbola D; Rasoanaivo P; Ratsimamanga S; Vial H
Mol Biochem Parasitol; 2006 Mar; 146(1):58-67. PubMed ID: 16313982
[TBL] [Abstract][Full Text] [Related]
5. Toward a novel metal-based chemotherapy against tropical diseases. 2. Synthesis and antimalarial activity in vitro and in vivo of new ruthenium- and rhodium-chloroquine complexes.
Sánchez-Delgado RA; Navarro M; Pérez H; Urbina JA
J Med Chem; 1996 Mar; 39(5):1095-99. PubMed ID: 8676344
[TBL] [Abstract][Full Text] [Related]
6. The mechanism of antimalarial action of [Au(CQ)(PPh(3))]PF(6): structural effects and increased drug lipophilicity enhance heme aggregation inhibition at lipid/water interfaces.
Navarro M; Castro W; Martínez A; Sánchez Delgado RA
J Inorg Biochem; 2011 Feb; 105(2):276-82. PubMed ID: 21194628
[TBL] [Abstract][Full Text] [Related]
7. Anti-malarial effect of novel chloroquine derivatives as agents for the treatment of malaria.
Yeo SJ; Liu DX; Kim HS; Park H
Malar J; 2017 Feb; 16(1):80. PubMed ID: 28212631
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo anti-malarial activity of tigecycline, a glycylcycline antibiotic, in combination with chloroquine.
Sahu R; Walker LA; Tekwani BL
Malar J; 2014 Oct; 13():414. PubMed ID: 25336038
[TBL] [Abstract][Full Text] [Related]
9. In vitro evaluation of chloroquine-loaded and heparin surface-functionalized solid lipid nanoparticles.
Muga JO; Gathirwa JW; Tukulula M; Jura WGZO
Malar J; 2018 Apr; 17(1):133. PubMed ID: 29606144
[TBL] [Abstract][Full Text] [Related]
10. Activity of piperaquine and other 4-aminoquinoline antiplasmodial drugs against chloroquine-sensitive and resistant blood-stages of Plasmodium falciparum. Role of beta-haematin inhibition and drug concentration in vacuolar water- and lipid-phases.
Warhurst DC; Craig JC; Adagu IS; Guy RK; Madrid PB; Fivelman QL
Biochem Pharmacol; 2007 Jun; 73(12):1910-26. PubMed ID: 17466277
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a selective, safe and novel anti-malarial compound with activity against chloroquine resistant strain of Plasmodium falciparum.
Agarwal A; Paliwal S; Mishra R; Sharma S; Kumar Dwivedi A; Tripathi R; Gunjan S
Sci Rep; 2015 Sep; 5():13838. PubMed ID: 26346444
[TBL] [Abstract][Full Text] [Related]
12. Uptake of a fluorescently tagged chloroquine analogue is reduced in CQ-resistant compared to CQ-sensitive Plasmodium falciparum parasites.
Reiling SJ; Rohrbach P
Malar J; 2019 Oct; 18(1):342. PubMed ID: 31590674
[TBL] [Abstract][Full Text] [Related]
13. 3-Iodo-4-aminoquinoline derivative sensitises resistant strains of Plasmodium falciparum to chloroquine.
Edaye S; Tazoo D; Bohle DS; Georges E
Int J Antimicrob Agents; 2016 Jun; 47(6):482-5. PubMed ID: 27211211
[TBL] [Abstract][Full Text] [Related]
14. Reemergence of chloroquine (CQ) analogs as multi-targeting antimalarial agents: a review.
Mushtaque M; Shahjahan
Eur J Med Chem; 2015 Jan; 90():280-95. PubMed ID: 25461328
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and in vitro evaluation of new chloroquine-chalcone hybrids against chloroquine-resistant strain of Plasmodium falciparum.
Sashidhara KV; Avula SR; Palnati GR; Singh SV; Srivastava K; Puri SK; Saxena JK
Bioorg Med Chem Lett; 2012 Sep; 22(17):5455-9. PubMed ID: 22850213
[TBL] [Abstract][Full Text] [Related]
16. Pentamethylcyclopentadienyl-rhodium and iridium complexes containing (N^N and N^O) bound chloroquine analogue ligands: synthesis, characterization and antimalarial properties.
Ekengard E; Kumar K; Fogeron T; de Kock C; Smith PJ; Haukka M; Monari M; Nordlander E
Dalton Trans; 2016 Mar; 45(9):3905-17. PubMed ID: 26829897
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antimalarial activity of new heterocyclic hybrids based on chloroquine and thiazolidinone scaffolds.
Rojas Ruiz FA; García-Sánchez RN; Estupiñan SV; Gómez-Barrio A; Torres Amado DF; Pérez-Solórzano BM; Nogal-Ruiz JJ; Martínez-Fernández AR; Kouznetsov VV
Bioorg Med Chem; 2011 Aug; 19(15):4562-73. PubMed ID: 21723734
[TBL] [Abstract][Full Text] [Related]
18. 4-Aminoquinoline quinolizidinyl- and quinolizidinylalkyl-derivatives with antimalarial activity.
Sparatore A; Basilico N; Parapini S; Romeo S; Novelli F; Sparatore F; Taramelli D
Bioorg Med Chem; 2005 Sep; 13(18):5338-45. PubMed ID: 16054368
[TBL] [Abstract][Full Text] [Related]
19. Synergistic interaction of a chloroquine metabolite with chloroquine against drug-resistant malaria parasites.
Kalkanidis M; Klonis N; Tschan S; Deady LW; Tilley L
Biochem Pharmacol; 2004 Apr; 67(7):1347-53. PubMed ID: 15013850
[TBL] [Abstract][Full Text] [Related]
20. Antiplasmodial activity of new 4-aminoquinoline derivatives against chloroquine resistant strain.
Sinha M; Dola VR; Agarwal P; Srivastava K; Haq W; Puri SK; Katti SB
Bioorg Med Chem; 2014 Jul; 22(14):3573-86. PubMed ID: 24906512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
